Cancer Research Institute

American nonprofit organization

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)

A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (April 2016) (Learn how and when to remove this message)

|

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Cancer Research Institute" – news · newspapers · books · scholar · JSTOR (November 2015) (Learn how and when to remove this message)

|

(Learn how and when to remove this message)

The Cancer Research Institute (CRI) is a US non-profit organization funding cancer research and based in New York City. They were founded in 1953 to develop immunologically-based treatments for cancer, and despite their name are a funding body for research rather than a research institute themselves, working with other institutes and organizations. It was founded by Helen Coley Nauts and Oliver R. Grace with a $2,000 grant from Nelson Rockefeller. CRI was created in honor of Nauts' father, William Coley (1862–1936), an American orthopedic surgeon and a pioneer of cancer immunotherapy. Grounded in Dr. Coley’s pioneering work, the Cancer Research Institute focuses on immunological treatments for cancer, both as a single treatment approach as well as a complement and enhancer to traditional treatments, such as chemotherapy and surgery.

The organization offers research grants to students, postdoctoral fellows, and investigators at medical research institutions throughout the world. It also funds clinical trials testing promising immunotherapies in a variety of cancer types and convenes scientific conferences for tumor immunologists.

## Awards

[edit]

The institute makes a number of awards for excellence in the field of cancer research.[1]

William B. Coley Award

The William B. Coley Award is given annually to one or more scientists for outstanding achievements in the field of basic immunology and cancer immunology. Awardees receive an honorary medal and $5,000 prize. It is named for the pioneer of cancer immunotherapy, William B. Coley.

Lloyd J. Old Award

The Lloyd J. Old Award in Cancer Immunology recognizes an active scientist whose outstanding and innovative research in cancer immunology has had a far-reaching impact on the cancer field. It is named after Lloyd J. Old, one of the founders and standard-bearers of the field of cancer immunology.

Frederick W. Alt Award

The Frederick W. Alt Award recognizes outstanding success in academia or industry for research that may have a potentially major impact on immunology. It is named in honor of geneticist Frederick W. Alt.

Other awards are the Oliver R. Grace Award and the Helen Coley Nauts Award.

## References

[edit]

1. ^ "Our Strategy & Impact". Cancer Research Institute. Retrieved 10 December 2014.

* "Cancer Research Institute". Cancer Research Institute.

Authority control databases

International|

* ISNI
* VIAF

National|

* United States
* 2
* Czech Republic

This article about a philanthropic or charitable organization is a stub. You can help Wikipedia by expanding it.

|

* v
* t
* e

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template